Fortress Biotech Inc. (FBIO)
NASDAQ · Healthcare
Fortress Biotech Inc. Operating Income 2013–2025
Fortress Biotech Inc. annual/quarterly operating income history and growth rate from 2013 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Fortress Biotech Inc. operating income for the quarter ending March 31, 2026 was -7.7 M, a 65.32% decrease year-over-year.
- Fortress Biotech Inc. operating income for the twelve months ending March 31, 2026 was -73.3 M, a 26.81% decrease year-over-year.
- Fortress Biotech Inc. annual operating income for 2025 was -70.2 M, a 36.38% decrease from 2024.
- Fortress Biotech Inc. annual operating income for 2024 was -110.4 M, a 22.46% decrease from 2023.
- Fortress Biotech Inc. annual operating income for 2023 was -142.3 M, a 30.08% decrease from 2022.
- Fortress Biotech Inc. annual operating income for 2022 was -203.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fortress Biotech Inc. Operating Income — FAQ
Fortress Biotech Inc. (FBIO) operating income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is Fortress Biotech Inc.'s operating income?
Fortress Biotech Inc. (FBIO) reported operating income of -$70M for fiscal 2025.
Where can I see FBIO's operating income history?
The chart and table above show Fortress Biotech Inc.'s operating income by year and by quarter, including the growth rate.